Skip to main content
. 2021 Nov 1;39:89–101. doi: 10.1016/j.jare.2021.10.010

Fig. 5.

Fig. 5

Chemical structures of deferoxamine (A), deferiprone (B), deferasirox (C), three of the most important US FDA-approved iron chelating compounds implicated in the treatment of iron overload, and FBS0701 (D).